0002088831-26-000001.txt : 20260527 0002088831-26-000001.hdr.sgml : 20260527 20260527111132 ACCESSION NUMBER: 0002088831-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260527 DATE AS OF CHANGE: 20260527 EFFECTIVENESS DATE: 20260527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kayak Therapeutics, Inc. CENTRAL INDEX KEY: 0002088831 ORGANIZATION NAME: EIN: 393869900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-585230 FILM NUMBER: 261023496 BUSINESS ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 BUSINESS PHONE: 917.892.9996 MAIL ADDRESS: STREET 1: 3317 BOWMAN AVENUE CITY: AUSTIN STATE: TX ZIP: 78703 D 1 primary_doc.xml X0708 D LIVE 0002088831 Kayak Therapeutics, Inc. 3317 BOWMAN AVENUE AUSTIN TX TEXAS 78703 917.892.9996 DELAWARE None None Corporation true 2025 Josiah Hornblower 317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Director Tyler Brous 317 Bowman Avenue Austin TX TEXAS 78703 Director Conor Richardson 3317 Bowman Avenue Austin TX TEXAS 78703 Executive Officer Taylor Schreiber 3317 Bowman Avenue Austin TX TEXAS 78703 Director Biotechnology Decline to Disclose 06b false 2026-05-12 false true false 0 25000000 11940000 13060000 false 55 0 0 0 false Kayak Therapeutics, Inc. Conor Richardson Conor Richardson Chief Financial Officer 2026-05-27